Highlights from the interdisciplinary consultation for diseases of the mouth in Basel;Erfahrungen aus der interdisziplinären Basler mundhö hlensprechstunde

Therapeutische Umschau

Volumn 61, Issue 5, 2004, Pages 295-301

  Podvinec, M ^a   Buchner S ^b   Lambrecht, Th ^b  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CARBON DIOXIDE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; GLUCOCORTICOID; GOLD; GRISEOFULVIN; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; LIDAZON; LOCASEPTIL NEO; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORABASE; PHENYTOIN; RETINOID; SALVIA MILTIORRHIZA EXTRACT; THALIDOMIDE; TITANIUM; TRIAMCINOLONE;

ANTISEPSIS; APHTHOUS STOMATITIS; BRUXISM; CARBON DIOXIDE LASER; CHRONIC DISEASE; CLINICAL PRACTICE; DERMATOLOGY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REGIMEN; EXPERIENCE; FACE DISORDER; GASTROENTEROLOGY; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNOLOGY; JAW DISEASE; LICHEN; LICHEN PLANUS; LICHENOID ERUPTION; MAXILLOFACIAL DISORDER; MEDICAL SPECIALIST; MOUTH DISEASE; ORTHODONTICS; OTORHINOLARYNGOLOGY; PARANEOPLASTIC SYNDROME; PEDIATRICIAN; PEMPHIGUS; PERIPHERAL NEUROPATHY; RECURRENT DISEASE; REVIEW; STEROID THERAPY; SWITZERLAND; SYSTEMIC DISEASE; TERATOGENICITY; TONGUE DISEASE;

EID: 2642532921     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.5.295     Document Type: Review

References (19)

1. Scully C, Chalacombe S. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Biol Med 2002; 13: 397-408.
2. Hertl M, Schuler G. Bullöse Autoimmundermatosen. Teil 1 Klassifikation. Hautarzt 2002; 53: 207-21.
3. Hertl M, Schuler G. Bullöse Autoimmundermatosen. Teil 2: Pathogenese. Hautarzt 2002; 53: 277-85.
4. Bowers K. Oral blistering diseases. Clinics Dermatol 2000; 18: 513-23.
5. Casiglia J, Woo S, Ahmed A. Oral involvement in autoimmune blistering diseases. Clinics Dermatol 2001; 19: 737-41.
6. Hertl M, Schuler G. Bullöse Autoimmundermatosen. teil 3: Diagnostik und Therapie. Hautarzt 2002; 53: 352-66.
7. Toth G, Jonkman M. Therapy of pemphigus. Clinics Dermatol 2001; 19: 761-7.
8. Abensour M, Grosshans E. Geographic tongue or benign migratory glossitis. Ann Dermatol Venereol 1999; 126: 849-52.
9. Byrd J, Bruce A, Rogers III R. Glossitis and other tongue disorders. Dermatol Clin 2003; 21: 123-34.
10. Joseph B, Savage N. Tongue pathology. Clinics Dermatol 2000; 18: 613-8.
11. Zunt S. Recurrent aphthous stomatitis. Dermatol Clin 2003; 21: 33-9.
12. Porter S, Hegarty A, Kaliakatsou F, Hodgson T, Scully C. Recurrent aphthous stomatitis. Clinics Dermatol 2000; 18: 569-78.
13. McCarty M, Garton R, Jorizzo J. Complex aphthosis and Behcet's disease. Dermatol Clin 2003; 21: 41-8.
14. MacPhail L. Topical and systemic therapy for recurrent aphthous stomatitis. Semin Cutan Med 24 Surg 1997; 16: 301-7.
15. McCarten BE. Psychological factors associated with oral lichen planus. J Oral Pathol Med 1995; 24: 273-5.
16. McCreary CE, McCarten BE. Clinical Management of Oral Lichen Planus. British Journal of Oral and Maxillofacial Surgery 1999; 37: 338-43.
17. Van der Meij EH, Smeele LE, Schepman KP, et al. A review of the recent literature regarding malignant transformation of oral lichen planus. Editors: Jacobsen J, Van Dis M. Oral Surgery 1999; 88: 308-10.
18. Henriksson E, Mattsson UH, Kansson J. Healing of lichenoid reactions following removal of amalgam-A clinical follow-up. J. Clin Periodontol 1995; 22: 287-94.
19. 2-Laser. Schweizer Monatsschrift im Druck; 2003.